Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL | Zendy

YuHsuan Joni Shao | Zendy; Peter C. Albertsen | Zendy; Calpurnyia B. Roberts | Zendy; Yong Lin | Zendy; Amit Mehta | Zendy; Mark N. Stein | Zendy; Robert S. DiPaola | Zendy; Grace L. LuYao | Zendy

Open Access

Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL

Author(s) -

YuHsuan Joni Shao,

Peter C. Albertsen,

Calpurnyia B. Roberts,

Yong Lin,

Amit Mehta,

Mark N. Stein,

Robert S. DiPaola,

Grace L. LuYao

Publication year - 2010

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2010.221

Subject(s) - medicine , prostate cancer , prostatectomy , confidence interval , prostate specific antigen , prostate , odds ratio , urology , epidemiology , cancer , logistic regression , gynecology , oncology

Despite controversy over the benefit of prostate-specific antigen (PSA) screening, little is known about risk profiles and treatment patterns in men diagnosed as having prostate cancer who have a PSA value less than or equal to 4.0 ng/mL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research